Skip to main content

Heron Therapeutics, Inc 10-Q for FY2024 Q3

Heron Therapeutics, Inc. (HRTX)

10-Q 2024-11-12 For: 2024-09-30
View Original
Added on April 09, 2026

About this 10-Q

Heron Therapeutics, Inc filed this 10-Q on November 12, 2024, covering the quarter ended September 30, 2024 (FY2024 Q3).

Headline figures

Quarter ended September 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$32.81M
up 4.4% from $31.43M a year earlier
Net loss
$4.85M
compared with a net loss of $25.01M a year earlier
Diluted EPS
-$0.03
compared with -$0.17 a year earlier